Network News
Basel, Switzerland, 8 May 2026 – Today, Lonza Group Ltd held its Annual General Meeting (AGM), led by the Chair of the Board of Directors, Jean-Marc Huët. 62.58% of the share capital was represented at the AGM, with attending and represented shareholders collectively holding a total of 43,948,027 shares. All Board members standing for re-election were re-elected, each for a further term in office until the completion of the AGM 2027. The following Board members stood for re-election: Jean-Marc Huët, Juan […]
read more
Hella Bühler Prize Awarded to DKFZ Researcher Angelika Feldmann
For her groundbreaking research on the regulation of gene activity, Angelika Feldmann has been awarded the 2026 Hella Bühler Prize, which comes with a grant of €100,000. Presented by Heidelberg University, the award is intended for young researchers in the Heidelberg research community who have already distinguished themselves through outstanding scientific achievements in cancer research. […]
read more
VectorBuilder Secures European Patent for MiniVec™, a Plasmid Backbone Advancing Safety and Manufacturability in Genetic Medicine
Small by design, built for the demands of modern genetic medicine across gene therapy, cell therapy, and vaccines Chicago, IL – May 5, 2026 – VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced that its MiniVec™ plasmid system has been granted a European patent, marking a significant milestone for the company’s proprietary plasmid DNA technology […]
read more
Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development
Chicago, April 21, 2026 – One of the most fundamental questions in biology is how a single fertilized egg produces the diverse cell types making up the body – from neurons and skin to muscle and blood – that bear the same genetic blueprint but distinct expression patterns. Now, a research team lead by Dr. Bruce Lahn, […]
read more
AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance
Global CDMO recognized for exceptional quality systems and regulatory track record; named finalist in Excellence in Client Service & Partnership and Manufacturing Operations categories SEATTLE – April 27, 2026 – AGC Biologics, your friendly CDMO expert, is the 2026 recipient of the Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance. The award recognizes the […]
read more
New “WHO Collaborating Centre for Novel Diagnostics for Infectious Diseases” at Heidelberg University Hospital
The Department of Infectious and Tropical Medicine at the Center for Infectious Diseases at Heidelberg University Hospital has been designated by the World Health Organization (WHO) as a “WHO Collaborating Center for Novel Diagnostics for Infectious Diseases.” As part of this collaboration, the department supports the WHO in achieving one of its fundamental goals: the […]
read more
SPT Labtech and EMBL GeneCore Collaborate to Advance Fully Walkaway Automation in Genomics Workflows
Cambridge, UK, and Heidelberg, Germany, 13 April 2026: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and the European Molecular Biology Laboratory’s Genomics Core Facility (EMBL GeneCore), today announced a collaboration to advance fully walkaway automated genomics workflows. As part of the collaboration, SPT Labtech’s firefly®+ […]
read more
AskBio’s Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency Berlin, Germany, and Durham, N.C., USA, April 20, 2026 – AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that it has introduced its proprietary, commercially ready […]
read more
BioMed X and Servier Launch First Research Team in France to Pioneer AI-Driven Antibody Engineering
BioMed X, a leading innovation hub for pharma, has officially launched its first research team at BioMed X France, marking the establishment of its presence in one of Europe’s fastest-growing life science ecosystems. The new team, Team ADB (AI-Empowered Design of Bispecific Antibodies), is based within the XSeed Labs incubator on the R&D campus of Servier in […]
read more
